Study Provides First Preclinical Evidence of a Bispecific Trifunctional Antibody–Induced Anti-Tumor Vaccination Effect in Neuroblastoma
Cancer Network,
A research team in Berlin has published what they say is the first evidence that a disialoganglioside 2–directed bispecific…